Ladprao General Hospital Public Company (LPH) Fair Value & Analysis
Healthcare · TH · Market cap 2.6B THB
Fair value as of: Jul 16, 2026
From 26 valuation models · updated 24 days ago
Fair value updated Jul 16, 2026, revised from 6.01 THB to 5.00 THB (−16.8%) since Jun 24, 2026. Share price +1.1% over the past month.
A strong business, screening 39% undervalued on our models.
What matters now
- The rarer combination: high quality (76/100) AND below fair value. That earns a closer look rather than a quick verdict.
- Our model range runs from 3.60 THB (bear) to 6.41 THB (bull), base 5.00 THB. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 76/100 (high quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 3.23 THB – 5.53 THB · fair‑value band 3.60 THB – 6.41 THB · the 3.60 THB price screens below the 5.00 THB fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Ladprao General Hospital Public Company (LPH) currently trades at 3.60 THB, while our model-based Fair Value estimate is 5.00 THB, implying the stock looks roughly 38.9% undervalued today. The Quality Score stands at 76/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Ladprao General Hospital Public Company generated revenue of 2.6B THB at a net margin of 7.7%. Revenue declined 1.4% year over year. It earns a return on equity of 11.7%. Net debt stands at 450M THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 3.60 THB (bear case) to 6.41 THB (bull case); at 3.60 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 39%, LPH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (7.37 THB) versus Asset-Based (1.83 THB). Highest evidence: Growth DCF (80).
Notify me when LPH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 74 · Market factors (momentum, volatility) 53
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. The company operates in two segments, Hospital and Scientific Testing & Inspection & Quality System Certification.
Full company description
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. The company operates in two segments, Hospital and Scientific Testing & Inspection & Quality System Certification. It is involved in the operation of hospitals, specialty medical centers, facilities participating in the social security program, and health centers. The company also offers medical services and packages for various applications, including orthopedic, gastrointestinal and liver, beauty and laser, eyes disease, pediatric, hear, women's health, ENT, surgery, health checkup, brain and nervous system, rehabilitation medicine and physical therapy, dental, skin, internal medicine, lasik, diabetic and chronic wounds, and social security. In addition, it provides scientific analytical and diagnostic services for food and agricultural, pharmaceutical, and environmental covering product analysis, calibration of instruments, inspections, and certifications in accordance with quality systems and international standards, such as consulting and training. Further, the company engages in health mobile checkup; nurse services in factories and agencies; sale of health and medical products; support and development of health-related businesses and associated real estate; and provision of research, development, cultivation, and distribution of herbal products for medical benefits. Ladprao General Hospital Public Company Limited was founded in 1990 and is based in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ladprao General Hospital Public Company reported revenue of 2.6B THB in FY2025 versus 2.5B THB in FY2021, a compound +0.8%/yr. Reported net income was 197M THB in FY2025, compounding −19.3%/yr from FY2021.
of which total revenue +7.7 pp · buybacks/dilution −1.6 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch LPH: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Ladprao General Hospital Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ladprao General Hospital Public Company (LPH) overvalued or undervalued?
What is the fair value of LPH?
What is the quality score of LPH?
What is the revenue of Ladprao General Hospital Public Company (LPH)?
What is the net profit margin of LPH?
Does Ladprao General Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ladprao General Hospital Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.